Browse: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 1 | 3 |
Pfizer, Inc. patentsThe following is a sampling of recent Pfizer, Inc. patent applications (USPTO Patent Application #, Patent Title) sorted by month.
June 2009 - Pfizer, Inc. patents
20090163493 - Benzene, pyridine, and pyridazine derivatives
May 2009 - Pfizer, Inc. patents
20090130695 - Gef-h1b: biomarkers, complexes, assays and therapeutic uses thereof
20090117132 - Anti-ctla-4 antibody and cpg-motif-containing synthetic oligodeoxynucleotide combination therapy for cancer treatment
20090118487 - P-cadherin antibodies
April 2009 - Pfizer, Inc. patents
20090111805 - Bicyclic heteroaromatic derivatives useful as anticancer agents
20090093452 - Pyrrole, thiophene, furan, imidazole, oxazole, and thiazole derivatives
20090093463 - Novel compounds of substituted and unsubtituted adamantyl amides
20090087446 - Combination motif immune stimulatory oligonucleotides with improved activity
20090087446 - Combination motif immune stimulatory oligonucleotides with improved activity
March 2009 - Pfizer, Inc. patents
20090074787 - Anti-ctla4 antibody and indolinone combination therapy for treatment of cancer
20090069316 - Novel quinoline derivatives
20090062296 - Prostaglandin derivatives
February 2009 - Pfizer, Inc. patents
20090054395 - Sulfonyl amide derivatives for the treatment of abnormal cell growth
20090048254 - Salts and polymorphs of a vegf-r inhibitor
January 2009 - Pfizer, Inc. patents
20090030076 - Prostaglandin derivatives
20090022728 - Methods of treating ophthalmic diseases
20090012085 - Dosage forms and methods of treatment using a tyrosine kinase inhibitor
20090005416 - Benzimidazole derivatives
April 2008 - Pfizer, Inc. patents
20080096916 - Drugs and prodrugs useful the treatment of energy balance in ruminants
20080096950 - Compounds useful in therapy
20080097097 - Process for preparing purine compounds
20080090829 - Substituted heteroaryl- and phenylsulfamoyl compounds
20080090861 - Therapeutic pyrazolyl thienopyridines
20080090873 - Sulfonamide derivatives
20080085884 - Melanin concentrating hormone receptor-1 antagonist pyridinones
20080085887 - Pyrido [4,3-d] pyrimidin-4 (3h) -one derivatives as calcium receptor antagonists
20080085919 - 1h-pyrazoles useful in therapy
March 2008 - Pfizer, Inc. patents
20080075784 - Taste making formulation comprising the drug in a dissolution-retarded form and/or cyclodextrin in a dissolution-enhanced form
20080076771 - Thrombopoietin receptor agonists
20080070887 - Diaryl ether derivatives and uses thereof
20080063708 - Pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase-forming materials
February 2008 - Pfizer, Inc. patents
20080050351 - Gene therapy approaches to supply apolipoprotein a-i agonists and their use to treat dyslipidemic disorder
January 2008 - Pfizer, Inc. patents
20080027088 - Imidazole-based hmg-coa reductase inhibitors
20080015343 - Azithromycin dosage forms with reduced side effects
20080009474 - Penem prodrugs
December 2007 - Pfizer, Inc. patents
20070299076 - Substituted 3-amino-pyrrolidino-4-lactams
20070282009 - Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors
November 2007 - Pfizer, Inc. patents
20070276010 - Aminopyrazole derivatives as gsk-3 inhibitors
20070270412 - Novel pharmaceuticals
20070265193 - Tetraazabenzo[e]azulene derivatives and analogs thereof
20070265303 - Amine derivatives
20070260056 - Process for preparing bicyclic pyrazolyl
October 2007 - Pfizer, Inc. patents
20070248611 - Methods wanted for treating unwanted weight loss or eating disorders by administering a trkb agonist
20070249025 - Enzymatic resolution of selective estrogen receptor modulators
20070249612 - Substituted 2h-[1,2,4]triazolo[4,3-a]pyrazines as gsk-3 inhibitors
September 2007 - Pfizer, Inc. patents
20070225291 - Substituted pyrazinone compounds for the treatment of inflammation
20070225333 - 3-heterocyclyl-4-phenyl-triazole derivatives as inhibitors of the vasopressin via receptor
20070219237 - Chromane derivatives
20070219274 - (r)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity
20070213314 - Dibenzyl amine compounds and derivatives
20070213371 - Dibenzyl amine compounds and derivatives
August 2007 - Pfizer, Inc. patents
20070203246 - Combinations of cholesterol ester transfer protein inhibitors and hmg coa reductase inhibitors for cardiovascular indications
20070196441 - Process for making orally consumable dosage forms
20070196483 - Taste-masked drugs in rupturing multiparticulates
20070197587 - Quinoline derivatives as crth2 antagonists
20070191319 - Treatment of conditions that present with low bone mass by continuous combination therapy with selective prostaglandin ep4 receptor agonists and an estrogen
20070191333 - Antibacterial agents
20070185078 - Substituted triazole derivatives as oxytocin antagonists
July 2007 - Pfizer, Inc. patents
20070163917 - Package and device for simultaneously maintaining low moisture and low oxygen levels
20070161664 - Therapeutic compounds
20070161666 - Pyrrolo[2,3-d]pyrimidine compounds
20070155838 - New method for treating urinary disorders
June 2007 - Pfizer, Inc. patents
20070148232 - Stabilized pharmaceutical solid compositions of low-solubility drugs and poloxamers, and stabilizing polymers
20070148236 - Pharmaceutical compositions of adsorbates of amorphous drug
20070149567 - Quinoline compounds
20070141143 - Solid compositions of low-solubility drugs and poloxamers
20070141684 - Preparation of gamma-amino acids having affinity for the alpha-2-delta protein
20070142448 - Chromane substituted benzimidazole derivatives
20070135457 - Pyrido[2,3-d]pyrimidine-2,4-diamines as pde2 inhibitors
May 2007 - Pfizer, Inc. patents
20070123507 - Process for converting heterocyclic ketones to amido-substituted heterocycles
20070110800 - Pharmaceutical composition having uniform drug distribution and potency
20070105856 - Cannabinoid receptor ligands and uses thereof
20070105909 - Compounds useful in therapy
20070099897 - Therapeutic compounds
April 2007 - Pfizer, Inc. patents
20070093525 - Triamide-substituted heterobicyclic compounds
20070087057 - Hydrogel-driven drug dosage form
March 2007 - Pfizer, Inc. patents
20070049759 - Methods for preparing n-arylated oxazolidinones via a copper catalyzed cross coupling
February 2007 - Pfizer, Inc. patents
20070027133 - Bicyclic pyrazolyl and imidazolyl compounds and uses thereof
20070027212 - Alpha 2 delta ligands for fibromyalgia and other disorders
January 2007 - Pfizer, Inc. patents
20070015205 - Crystal structure of phosphodiesterase 5 and use thereof
20070009536 - Novel madcam antibodies
20070010464 - Avermectin and praziquantel combination therapy
20070004774 - Cept inhibitors and metabolites thereof
December 2006 - Pfizer, Inc. patents
20060293347 - Pharmaceutically active compounds
20060281812 - Novel 3,3-diphenylpropylamines useful in therapy
November 2006 - Pfizer, Inc. patents
20060263412 - Confectionery products for the treatment of dry mouth
October 2006 - Pfizer, Inc. patents
20060231453 - Device and method for packaging and merchandising personal healthcare products
20060233954 - Method and apparatus for producing a uniform film on a substrate
###
This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Pfizer, Inc. in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Pfizer, Inc. with additional patents listed. Browse our Agent directory for other possible listings.
###
FreshPatents.com Support
|
REGISTER now for FREE 
